Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10057542HBVENSG00000120889.13protein_codingTNFRSF10BNoNo8795O14763
TVIS30009500HIVENSG00000120889.13protein_codingTNFRSF10BNoNo8795O14763
TVIS30068625HIVENSG00000120889.13protein_codingTNFRSF10BNoNo8795O14763
TVIS30068626HIVENSG00000120889.13protein_codingTNFRSF10BNoNo8795O14763
TVIS20007492HPVENSG00000120889.13protein_codingTNFRSF10BNoNo8795O14763
TVIS20007491HPVENSG00000120889.13protein_codingTNFRSF10BNoNo8795O14763
TVIS20018197HPVENSG00000120889.13protein_codingTNFRSF10BNoNo8795O14763
TVIS44050674HTLV-1ENSG00000120889.13protein_codingTNFRSF10BNoNo8795O14763
TCGA Plot Options
Drug Information
GeneTNFRSF10B
DrugBank IDDB06599
Drug NameLexatumumab
Target IDBE0003433
UniProt IDO14763
Regulation Type
PubMed IDs18056199; 17671142
CitationsZhang X, Li W, Olumi AF: Low-dose 12-O-tetradecanoylphorbol-13-acetate enhances tumor necrosis factor related apoptosis-inducing ligand induced apoptosis in prostate cancer cells. Clin Cancer Res. 2007 Dec 1;13(23):7181-90.@@Maddipatla S, Hernandez-Ilizaliturri FJ, Knight J, Czuczman MS: Augmented antitumor activity against B-cell lymphoma by a combination of monoclonal antibodies targeting TRAIL-R1 and CD20. Clin Cancer Res. 2007 Aug 1;13(15 Pt 1):4556-64.
GroupsInvestigational
Direct ClassificationPeptides
SMILES
Pathways
PharmGKB
ChEMBL